ABEO Reports $5.8M Revenue, $71.2M Net Income, $191.4M Cash, Launches ZEVASKYN Commercial Treatment
Abeona Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.63
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS